<DOC>
	<DOCNO>NCT00380367</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability Quadrivalent Human Papilloma Virus ( HPV ) vaccine healthy females 9 15 year age India . Quadrivalent HPV Vaccine compose L1 virus-like particle ( VLPs ) HPV type 6 , 11 , 16 , 18 .</brief_summary>
	<brief_title>Safety , Tolerability Immunogenicity HPV ( Human Papilloma Virus ) Vaccine Healthy Females 9 15 Years Age India ( V501-029 )</brief_title>
	<detailed_description />
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Females Age 9 To 15 Years Females Not Sexually Active And Not Plan On Becoming Sexually Active During The Study No Fevers 24 Hours Prior To The First Injection Participant Had Received A Prior Vaccination With A HPV Vaccine Participant Has Allergies To Vaccine Component Including Aluminum And Yeast Participant Has ( Human Immunodeficiency Virus ) HIV Infection Participant Is Immunocompromised Participant Received Or Plans To Receive BloodDerived Product Within 6 Months Prior To The First Injection Participant Received Or Plans To Receive Immune Globulin Preparation Within 6 Months To The First Injection</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>